Daiwa Securities Group
QNCX icon

Daiwa Securities Group’s Quince Therapeutics QNCX Stock Holding History

Daiwa Securities Group’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 1369
2022
Q3 		$0 Hold
1
– – ﹤0.01% 1382
2022
Q2 		$0 Hold
1
– – ﹤0.01% 1412
2022
Q1 		$1K Hold
1
– – ﹤0.01% 1332
2021
Q4 		$1K Hold
1
– – ﹤0.01% 1352
2021
Q3 		$9K Buy
+1
New +$15.9K ﹤0.01% 1152
2021
Q2 		– Hold
0
– – – 1115
2021
Q1 		– Hold
0
– – – 1158
2020
Q4 		– Hold
0
– – – 1134

Other funds holding QNCX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Daiwa Securities Group's QNCX Position: Q4 2022 in Review

Daiwa Securities Group sold out of Quince Therapeutics (QNCX) in Q4 2022, closing a stake of 1 share.

Daiwa Securities Group first reported a position in QNCX in Q3 2021 and held it in 5 quarters. The position peaked at $9K in Q3 2021. 48 funds tracked by Wall St. Rank hold QNCX as of Q4 2022.

  • Daiwa Securities Group reported no remaining Quince Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 1 Quince Therapeutics share in Q4 2022.
  • Daiwa Securities Group first reported a position in Quince Therapeutics in Q3 2021 and held it in 5 quarters.
  • Daiwa Securities Group's Quince Therapeutics position peaked at $9K in Q3 2021.
  • 48 funds tracked by Wall St. Rank held Quince Therapeutics as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.